Summary of Significant Accounting Policies (Schedule of Significant Expense Categories of Reporting Segment) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Summary of Significant Accounting Policies [Abstract]
Revenue	$ 176,034	$ 125,808	$ 87,174
Less :
Cost of revenue	40,837	31,359	29,123
Research and development expenses:
Research and development	38,673	25,983	22,330
Regulatory and clinical	26,245	17,534	13,524
Selling, general and administrative expenses:
Sales	75,709	66,895	53,374
Marketing	19,146	14,470	9,949
General and administrative	39,490	30,789	31,788
Loss from operations	(64,066)	(61,222)	(72,914)
Other income (expense), net	(52,801)	(35,151)	(22,194)
Provision for income taxes	76	(53)	(547)
Net loss	$ (116,791)	$ (96,426)	$ (95,655)